CTalk
BioMeat: “Protein cannot come only from animals anymore”
At the Poalim Hi-Tech and Calcalist Road Show, CEO of BioMeat Gilles Gamon explained why he’s banking on foodtech
11:3809.12.21
“Foodtech is easy to understand, it’s 5-10 years where a lot of projects are developed in order to provide the bridge for being able to feed the coming population,” explained CEO of BioMeat, Gilles Gamon. “We have extensively used all the resources and we see that today it is having a very big and bad impact on the weather and the price of feeding the population.”
BioMeat is a public research and development partnership for foodtech investment traded on the Israeli stock exchange. To date, it has invested in companies like Rilbite, More Foods, and Ovo, technologies Gamon claims are “going to be a revolution in the future.”
He continued: “Tomorrow there will still be a need for protein to feed the coming population, and protein cannot come only from animals anymore, and so a lot of new projects are coming and those projects are going to be really the food of the future. That’s why we are here and out of all the tech we invest in today, I still think it is the best way to place your money because investments can be good in the future.”
You can watch the entire exchange in the video above.
